Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q3

4078.TEDINET S100Q2X8
Period2022-04-01 → 2022-12-31
Filed2023-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥63.8bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥59.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥4.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥6.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥4.7bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥5.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥7.5bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥5.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥131.3bnat 2022-12-31Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥123.6bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥45.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥85.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥81.1bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥207.792022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.312022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥315.692021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.842021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio62.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.6%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-12-31¥58.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥57.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥575m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥5.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥233m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥394m
—segment totalrevenue2022-04-01 → 2022-12-31¥64.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥63.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥808m
—segment totalsegment profit2022-04-01 → 2022-12-31¥5.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥1.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-12-31¥54.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-12-31¥53.4bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥765m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-12-31¥7.1bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥258m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥454m
—segment totalrevenue2021-04-01 → 2021-12-31¥60.6bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥59.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥1.0bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥7.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 378
ItemContextValueUnit
Impairment loss elPrior1YTDDuration－JPY
Impairment loss elCurrentYTDDuration35000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration109000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration81000000JPY
Loss on sales of investment securities elPrior1YTDDuration247000000JPY
Loss on sales of investment securities elCurrentYTDDuration－JPY
Loss on valuation of investment securities elPrior1YTDDuration0JPY
Loss on valuation of investment securities elCurrentYTDDuration－JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration539000000JPY
Extraordinary lossCurrentYTDDuration117000000JPY
Income before income taxesPrior1YTDDuration7473000000JPY
Income before income taxesCurrentYTDDuration5042000000JPY
Income taxesPrior1YTDDuration1948000000JPY
Income taxesCurrentYTDDuration1469000000JPY
Profit lossPrior1YTDDuration5525000000JPY
Profit lossCurrentYTDDuration3573000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration250000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration210000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration5274000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration3363000000JPY
Profit lossPrior1YTDDuration5525000000JPY
Profit lossCurrentYTDDuration3573000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1451000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-122000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration0JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-61000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration89000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration928000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-16000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration-1378000000JPY
Other comprehensive incomeCurrentYTDDuration744000000JPY
Comprehensive incomePrior1YTDDuration4146000000JPY
Comprehensive incomeCurrentYTDDuration4317000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration3833000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3823000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration313000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration493000000JPY
Discounted trade notes receivablePrior1YearInstant0JPY
Discounted trade notes receivableCurrentQuarterInstant－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00780-000ChemicalReportableSegmentsMember53353000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00780-000MedicineAndHealthCareReportableSegmentsMember6269000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember59623000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration59623000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00780-000ChemicalReportableSegmentsMember765000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00780-000MedicineAndHealthCareReportableSegmentsMember258000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember1023000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass